Gene therapy
Companies that develop one-time treatments delivering a working gene into the body to treat genetic diseases.
−22.0%
over 3 months · S&P 500 −2.1%
Key indicators
Health
44 / 100
Fragile
Solid
Up over 1 year
6 of 17
Volatility
77%
Calm
Choppy
Profitability
−196%
Low
High
Health and price: against the other tags.
Key indicators
When a figure has a bar, the marker places it among its peers, and the further right it sits, the more the figure beats the others. Green marks the best third, red the weakest and white anything in between. Some figures stay white wherever they sit, like price, pace or holding time, because neither side is better there.
The 17 companies
KRYS
−9.1%
SRPT
−11.6%
PGEN
−30.7%
Size: weight in the tag. Color: move over the period.
See all companies
See all companies
K
Krystal Biotech
KRYS
44.4%
−9.1%
S
Sarepta Therapeutics
SRPT
9.5%
−11.6%
P
Precigen
PGEN
8.3%
−30.7%
R
Ultragenyx Pharmaceutical
RARE
7.9%
−38.5%
T
Taysha Gene Therapies
TSHA
6.9%
−34.0%
M
MeiraGTx Holdings
MGTX
4.5%
−33.3%
S
Solid Biosciences
SLDB
3.4%
−24.8%
F
4D Molecular Therapeutics
FDMT
3.3%
−15.9%
R
REGENXBIO
RGNX
2.7%
−32.6%
N
Neurogene
NGNE
2.4%
−34.8%
I
Opus Genetics
IRD
1.7%
+9.0%
O
Ocugen
OCGN
1.6%
−39.8%
R
Rocket Pharmaceuticals
RCKT
1.2%
−32.4%
L
Lexeo Therapeutics
LXEO
1.2%
−42.4%
A
Abeona Therapeutics
ABEO
0.7%
−59.3%
G
Greenland Mines
GRML
0.3%
−63.8%
Q
uniQure
QURE
−50.4%